Antispasticity medications: uses and limitations of enteral therapy

Am J Phys Med Rehabil. 2004 Oct;83(10 Suppl):S50-8. doi: 10.1097/01.phm.0000141132.48673.fa.
No abstract available

Publication types

  • Review

MeSH terms

  • 4-Aminopyridine / therapeutic use
  • Acetates / therapeutic use
  • Adrenergic alpha-Agonists / therapeutic use
  • Amines*
  • Baclofen / therapeutic use
  • Benzodiazepines / therapeutic use
  • Cyclohexanecarboxylic Acids*
  • Cyproheptadine / therapeutic use
  • Dantrolene / therapeutic use
  • Dronabinol / therapeutic use
  • Gabapentin
  • Glycine / therapeutic use
  • Humans
  • Muscle Relaxants, Central / therapeutic use
  • Muscle Spasticity / drug therapy*
  • Neuroprotective Agents / therapeutic use
  • Piracetam / therapeutic use
  • Serotonin Antagonists / therapeutic use
  • gamma-Aminobutyric Acid*

Substances

  • Acetates
  • Adrenergic alpha-Agonists
  • Amines
  • Cyclohexanecarboxylic Acids
  • Muscle Relaxants, Central
  • Neuroprotective Agents
  • Serotonin Antagonists
  • Benzodiazepines
  • Cyproheptadine
  • gamma-Aminobutyric Acid
  • Gabapentin
  • Dronabinol
  • 4-Aminopyridine
  • Dantrolene
  • Baclofen
  • Glycine
  • Piracetam